Invasive lobular carcinoma (ILC) is the most common of the breast cancer special types,
accounting for up to 15% of all breast cancer cases. ILCs are noted for their lack of E …

The current histological classification of in‐situ and invasive lobular carcinomas (ILCs)
includes different morphological variants, some of which have been recently described. In …

Adenoid cystic carcinoma (AdCC) is a rare triple-negative breast cancer analogous to its
extramammary counterparts. Diagnosis of the more aggressive solid-basaloid variant of …

This review reflects a collaboration between the American Registry of Pathology (the
publisher of the Armed Forces Institute of Pathology Fascicles) and Annals of Diagnostic …

Simple Summary We present a meta-analysis of invasive lobular carcinoma (ILC)
sequencing data to provide a unified resource for ILC research. A large amount of data has …

The differential diagnosis of malignant spindle cell neoplasms in the breast most frequently
rests between malignant phyllodes tumor (MPT) and metaplastic carcinoma (MBC) …

Lobular carcinoma in situ (LCIS) is a non-invasive proliferation of atypical dyscohesive
epithelial cells characterized by loss or functional alteration of E-cadherin-mediated cell …

Lobular carcinoma in situ (LCIS) is currently classified as classic (CLCIS), florid (FLCIS), and
pleomorphic (PLCIS). Given the rarity of FLCIS and PLCIS, information on their clinico …

Special histologic subtypes of breast cancer (BC) exhibit unique phenotypes and molecular
profiles with diagnostic and therapeutic implications, often differing in behavior and clinical …

Invasive lobular carcinoma (ILC) is a low‐to intermediate‐grade histological breast cancer
type caused by mutational inactivation of E‐cadherin function, resulting in the acquisition of …